Journal
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL
Volume 7, Issue 1, Pages 29-34Publisher
PRO PHARMA COMMUNICATIONS INT
DOI: 10.5639/gabij.2018.0701.007
Keywords
Biological; biosimilar; patent
Categories
Ask authors/readers for more resources
Although small molecule drugs still dominate the global pharmaceutical market in terms of numbers, biologicals are making a significant dent. However, the high cost of biologicals is putting increasing pressure on healthcare budgets, thus opening the door to biosimilars. With patents on originator biologicals expiring, biosimilars are expected to take an increasing share of the biologicals market. In light of these facts, this paper gives estimated patent expiry dates for some of the best-selling biologicals.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available